This page contains reports on premises where an infection prevention and control lapse was identified through the assessment of a complaint or referral, or through communicable disease surveillance. It does not include reports of premises which were investigated following a complaint or referral where no infection prevention and control lapse was ultimately identified.
These reports are not exhaustive and do not guarantee that those premises listed and not listed are free of infection prevention and control lapses. Identification of lapses is based on assessment and investigation of a premises at a point-in-time, and these assessments and investigations are triggered when potential infection prevention and control lapses are brought to the attention of the local medical officer of health.
Reports are posted on the website of the board of health in which the premises is located. Reports are posted on a premises-by-premises basis, i.e., will correspond with one site only. Should you have questions about any posted lapse, please contact the Control of Infectious Diseases/Infection Control Program at 416-338-8400.
Premise/facility under investigation (name and address) | Focus Medical 1881 Yonge Street, Suite 503 Toronto, Ontario M4S 3C4 |
---|---|
Type of premise/facility: (E.g. clinic, personal services setting) | Medical Clinic |
Date Board of Health became aware of IPAC lapse | November 18, 2020 |
Date of Initial Report posting | November 26, 2020 |
Date of Initial Report update(s) (if applicable) | Not applicable |
How the IPAC lapse was identified | Other |
Summary Description of the IPAC Lapse |
|
Did the IPAC lapse involve a member of a regulatory college? | Yes |
---|---|
If yes, was the issue referred to the regulatory college? | Yes |
Were any corrective measures recommended and/or implemented? | Yes |
Please provide further details/steps |
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) | A Verbal Order was issued on November 19, 2020 to immediately stop the use of the sterilizer. |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Date of Final Report posting: | January 5, 2021 |
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
Verbal order was issued on November 19, 2020. |
---|---|
Brief description of corrective measures taken | As of November 27, 2020, Toronto Public Health (TPH) verified that the clinic has complied with all recommendations. This includes:
|
Date all corrective measures were confirmed to have been completed |
November 27, 2020 |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Name | Cecilia Alterman |
---|---|
Title | Manager, Control of Infectious Diseases/Infection Control |
email address | Cecilia.Alterman@toronto.ca |
Phone number | 416-338-8065 |
Premise/facility under investigation (name and address) | White Willow Dental 1940 Eglinton Ave. East, Suite 102 Toronto M1L 4R1 |
---|---|
Type of premise/facility: (E.g. clinic, personal services setting) | Dental clinic |
Date Board of Health became aware of IPAC lapse | November 12, 2020 |
Date of Initial Report posting | November 26, 2020 |
Date of Initial Report update(s) (if applicable) | Not applicable |
How the IPAC lapse was identified | Other |
Summary Description of the IPAC Lapse |
|
Did the IPAC lapse involve a member of a regulatory college? | Yes |
---|---|
If yes, was the issue referred to the regulatory college? | Yes |
Were any corrective measures recommended and/or implemented? |
|
Please provide further details/steps |
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) |
|
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Date of Interim Report posting: | December 21, 2020 |
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
Not applicable |
Brief description of corrective measures taken |
|
Date all corrective measures were confirmed to have been completed |
Any additional comments (Do not include any personal information or personal health information) | PHO courses to be started; completion in six months |
Name | Cecilia Alterman |
---|---|
Title | Manager, Control of Infectious Diseases/Infection Control |
email address | Cecilia.Alterman@toronto.ca |
Phone number | 416-338-8065 |
Premise/facility under investigation (name and address) | Birchmount Dental Group 2000 Eglinton Avenue E, #3H Scarborough, ON, M1L2M6 |
---|---|
Type of premise/facility: (E.g. clinic, personal services setting) | Dental clinic |
Date Board of Health became aware of IPAC lapse | February 12, 2020 |
Date of Initial Report posting | February 24, 2020 |
Date of Initial Report update(s) (if applicable) | Not applicable |
How the IPAC lapse was identified | Other |
Summary Description of the IPAC Lapse |
|
Did the IPAC lapse involve a member of a regulatory college? | Yes |
---|---|
If yes, was the issue referred to the regulatory college? | Yes |
Were any corrective measures recommended and/or implemented? | Yes |
Please provide further details/steps | Infection Prevention and Control (IPAC) Audit conducted by Toronto Public Health (TPH) on February 14, 2020.
Items to be addressed include:
Stop performing Immediate Use Steam Sterilization (also known as Flash Sterilization). |
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) | Not applicable |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Date of Final Report posting: | February 24, 2020 |
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
Not applicable |
---|---|
Brief description of corrective measures taken | As of February 20, 2020, TPH verified compliance with February 14, 2020 IPAC recommendations. |
Date all corrective measures were confirmed to have been completed |
February 20, 2020 |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Name | Danielle R. Steinman |
---|---|
Title | Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control |
Email address | Danielle.Steinman@toronto.ca |
Phone number | 416-338-8400 |
Premise/facility under investigation (name and address) | Scarborough Health Network Hospital – Centenary Site 2867 Ellesmere Road Toronto, Ontario M1E 4B9 |
---|---|
Type of premise/facility: (E.g. clinic, personal services setting) | Diagnostic imaging unit in hospital |
Date Board of Health became aware of IPAC lapse | November 18, 2019 |
Date of Initial Report posting | February 14, 2020 |
Date of Initial Report update(s) (if applicable) | Not applicable |
How the IPAC lapse was identified | Other |
|
Did the IPAC lapse involve a member of a regulatory college? | Yes |
---|---|
If yes, was the issue referred to the regulatory college? | Yes |
Were any corrective measures recommended and/or implemented? |
|
Please provide further details/steps |
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) | Not applicable |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Name | Cecilia Alterman |
---|---|
Title | Manager, Control of Infectious Diseases/Infection Control |
email address | Cecilia.Alterman@toronto.ca |
Phone number | 416-338-8065 |
Premise/facility under investigation (name and address) | Warden Woods Medical Centre 99 Firvalley Court Scarborough, ON M1L1P2 |
---|---|
Type of premise/facility: (E.g. clinic, personal services setting) | Medical Clinic |
Date Board of Health became aware of IPAC lapse | June 10, 2019 |
Date of Initial Report posting | February 13, 2020 |
Date of Initial Report update(s) (if applicable) | Not applicable |
How the IPAC lapse was identified | Other |
Summary Description of the IPAC Lapse |
|
Did the IPAC lapse involve a member of a regulatory college? | Yes |
---|---|
If yes, was the issue referred to the regulatory college? | Yes |
Were any corrective measures recommended and/or implemented? | Yes |
Please provide further details/steps | Infection Prevention and Control (IPAC) Audit conducted by Toronto Public Health (TPH) on July 3, 2019 and July 10, 2019.
Items to be addressed include:
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) | July 10, 2019 – Health Protection and Promotion Act (HPPA) Verbal Order was served. |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Date of Final Report posting: | February 13, 2020 |
Date any order(s) or directive(s) were issued to the owner/operator (if applicable) |
July 10, 2019 – Health Protection and Promotion Act (HPPA) Verbal Order was served. |
---|---|
Brief description of corrective measures taken | As of January 28, 2020, TPH verified compliance with July 10, 2019 IPAC recommendations. |
Date all corrective measures were confirmed to have been completed |
January 28, 2020 |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Name | Danielle R. Steinman |
---|---|
Title | Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control |
Email address | Danielle.Steinman@toronto.ca |
Phone number | 416-338-8400 |
Premise/facility under investigation (name and address) | Toronto Head and Neck Clinic 101-491 Eglinton Ave W Toronto, ON M5N 1A7 |
---|---|
Type of premise/facility: (E.g. clinic, personal services setting) | Clinic |
Date Board of Health became aware of IPAC lapse | November 21, 2018 |
Date of Initial Report posting | June 27, 2019 |
Date of Initial Report update(s) (if applicable) | Not applicable |
How the IPAC lapse was identified | Other |
Summary Description of the IPAC Lapse |
|
Did the IPAC lapse involve a member of a regulatory college? | Yes |
---|---|
If yes, was the issue referred to the regulatory college? | No |
Were any corrective measures recommended and/or implemented? | Yes |
Please provide further details/steps |
|
Date any order(s) or directive(s) were issued to the owners/operators (if applicable) | Verbal Order served on November 23, 2018
Letter of Recommendations – December 19, 2018 |
Any Additional Comments (Do not include any personal information or personal health information) | Not applicable |
---|
Name | Danielle R. Steinman |
---|---|
Title | Manager, BBD IPAC Team, Control of Infectious Diseases/Infection Control |
Email address | Danielle.Steinman@toronto.ca |
Phone number | 416-338-8400 |